New Translational Science Team Created In US FDA’s CDER To Aid Rare Disease Drug Development

 
• By Derrick Gingery
  
rare disease blocks
The translational science team would be similar to one working on real-world evidence. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet